Cargando…
“Waiting for DAAs”: A retrospective chart review of patients with untreated hepatitis C in Rwanda
BACKGROUND: Access to treatment for hepatitis C virus (HCV) in sub-Saharan Africa is extremely limited. With the advent of direct acting antivirals (DAAs), highly effective and easy-to-deliver oral regimens are now available on the global market. This study was conducted to understand the background...
Autores principales: | Gupta, Neil, Kabahizi, Jules, Mukabatsinda, Constance, Walker, Timothy David, Musabeyezu, Emmanuel, Kiromera, Athanase, Van Nuil, Jennifer Ilo, Steiner, Kevin, Mukherjee, Joia, Nsanzimana, Sabin, Mbituyumuremyi, Aimable |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360324/ https://www.ncbi.nlm.nih.gov/pubmed/28323868 http://dx.doi.org/10.1371/journal.pone.0174148 |
Ejemplares similares
-
Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda
por: Grant, Philip, et al.
Publicado: (2020) -
Controlling hepatitis C in Rwanda: a framework for a national response
por: Mbituyumuremyi, Aimable, et al.
Publicado: (2018) -
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators
por: Serumondo, Janvier, et al.
Publicado: (2020) -
Viral load detection and management on first line ART in rural Rwanda
por: Ndagijimana Ntwali, Jean de Dieu, et al.
Publicado: (2019) -
Hepatitis C virus and HIV co-infection among pregnant women in Rwanda
por: Mutagoma, Mwumvaneza, et al.
Publicado: (2017)